183 related articles for article (PubMed ID: 33704614)
1. NMR metabolomic profiles associated with long-term risk of prostate cancer.
Lécuyer L; Victor Bala A; Demidem A; Rossary A; Bouchemal N; Triba MN; Galan P; Hercberg S; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Vasson MP; Deschasaux-Tanguy M; Savarin P; Touvier M
Metabolomics; 2021 Mar; 17(3):32. PubMed ID: 33704614
[TBL] [Abstract][Full Text] [Related]
2. NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer.
Lécuyer L; Victor Bala A; Deschasaux M; Bouchemal N; Nawfal Triba M; Vasson MP; Rossary A; Demidem A; Galan P; Hercberg S; Partula V; Le Moyec L; Srour B; Fiolet T; Latino-Martel P; Kesse-Guyot E; Savarin P; Touvier M
Int J Epidemiol; 2018 Apr; 47(2):484-494. PubMed ID: 29365091
[TBL] [Abstract][Full Text] [Related]
3. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort.
Lécuyer L; Dalle C; Lyan B; Demidem A; Rossary A; Vasson MP; Petera M; Lagree M; Ferreira T; Centeno D; Galan P; Hercberg S; Deschasaux M; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Durand S; Pujos-Guillot E; Touvier M
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1300-1307. PubMed ID: 31164347
[TBL] [Abstract][Full Text] [Related]
4. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
[TBL] [Abstract][Full Text] [Related]
5. Prospective serum metabolomic profile of prostate cancer by size and extent of primary tumor.
Huang J; Mondul AM; Weinstein SJ; Karoly ED; Sampson JN; Albanes D
Oncotarget; 2017 Jul; 8(28):45190-45199. PubMed ID: 28423352
[TBL] [Abstract][Full Text] [Related]
6. Prospective serum metabolomic profiling of lethal prostate cancer.
Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
8. Plasma Metabolomic Profiles and Risk of Advanced and Fatal Prostate Cancer.
Wang Y; Jacobs EJ; Carter BD; Gapstur SM; Stevens VL
Eur Urol Oncol; 2021 Feb; 4(1):56-65. PubMed ID: 31378665
[TBL] [Abstract][Full Text] [Related]
9. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of patients with and without prostate cancer using urine
Hasubek AL; Wang X; Zhang E; Kobus M; Chen J; Vandergrift LA; Kurreck A; Ehret F; Dinges S; Hohm A; Tilgner M; Buko A; Habbel P; Nowak J; Mercaldo ND; Gusev A; Feldman AS; Cheng LL
Magn Reson Chem; 2023 Dec; 61(12):740-747. PubMed ID: 37654196
[TBL] [Abstract][Full Text] [Related]
11. A decade in prostate cancer: from NMR to metabolomics.
DeFeo EM; Wu CL; McDougal WS; Cheng LL
Nat Rev Urol; 2011 May; 8(6):301-11. PubMed ID: 21587223
[TBL] [Abstract][Full Text] [Related]
12. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
[TBL] [Abstract][Full Text] [Related]
13. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes.
Dudka I; Lundquist K; Wikström P; Bergh A; Gröbner G
J Transl Med; 2023 Nov; 21(1):860. PubMed ID: 38012666
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study.
Mondul AM; Moore SC; Weinstein SJ; Karoly ED; Sampson JN; Albanes D
Int J Cancer; 2015 Nov; 137(9):2124-32. PubMed ID: 25904191
[TBL] [Abstract][Full Text] [Related]
16. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort.
Lécuyer L; Dalle C; Micheau P; Pétéra M; Centeno D; Lyan B; Lagree M; Galan P; Hercberg S; Rossary A; Demidem A; Vasson MP; Partula V; Deschasaux M; Srour B; Latino-Martel P; Druesne-Pecollo N; Kesse-Guyot E; Durand S; Pujos-Guillot E; Manach C; Touvier M
Eur J Nutr; 2020 Dec; 59(8):3425-3439. PubMed ID: 31927670
[TBL] [Abstract][Full Text] [Related]
17. Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based metabolomics: A case-control study nested in the Northern Sweden Health and Disease Study.
Östman JR; Pinto RC; Ebbels TMD; Thysell E; Hallmans G; Moazzami AA
Int J Cancer; 2022 Dec; 151(12):2115-2127. PubMed ID: 35866293
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics analysis of seminal plasma in patients with idiopathic Oligoasthenoteratozoospermia using high-resolution NMR spectroscopy.
Mumcu A; Karaer A; Dogan B; Tuncay G
Andrology; 2020 Mar; 8(2):450-456. PubMed ID: 31520509
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
